[NH2:1][C:2]1[C:10]2[C:9]3[CH2:11][CH2:12][CH2:13][C:8]=3[S:7][C:6]=2[N:5]=[C:4]([CH3:14])[C:3]=1[C:15]([CH:17]1[CH2:19][CH2:18]1)=[O:16].[H-].[Na+].Br[CH2:23][CH2:24][CH2:25][CH2:26][CH2:27]Br>CN(C=O)C>[CH:17]1([C:15]([C:3]2[C:4]([CH3:14])=[N:5][C:6]3[S:7][C:8]4[CH2:13][CH2:12][CH2:11][C:9]=4[C:10]=3[C:2]=2[N:1]2[CH2:27][CH2:26][CH2:25][CH2:24][CH2:23]2)=[O:16])[CH2:19][CH2:18]1To a stirred solution of 12 mg (0.044 mmol) of (4-amino-6-methyl-2,3-dihydro-1H-8-thia-7-aza-cyclopenta[a]inden-5-yl)-cyclopropyl-methanone in 2 ml DMF was added 3.0 mg (0.066 mmol) NaH (55% in oil). After 20 minutes, 10 □l (0.044 mmol) of 1,5-dibromo-pentane and stirring was continued at RT over the night. The mixture was poured onto water and extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate and concentrated in vacuo. Flash chromatography (heptane/ethyl acetate 6:1) afforded 8 mg (54%) cyclopropyl-(6-methyl-4-piperidin-1-yl-2,3-dihydro-1H-8-thia-7-aza-cyclopenta[a]inden-5-yl)-methanone as a white solid. ES-MS m/e (%): 341 (M+H+, 100).
読み込み中…